Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Lancet Neurol. 2011 Jul 6;10(8):702–709. doi: 10.1016/S1474-4422(11)70148-X

Table 5.

APOE ε2 and ε4 and 90-day mortality and poor functional outcome

Phenotype Allele Discovery Replication I Replication II All subjects
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Lobar ICH Mortality APOE ε2 1·60 (1·13 – 2·25) 0·008 1·52 (1·06 – 2·17) 0·011 1·40 (1·01 – 1·93) 0·043 1·50 (1·23 – 1·82) 2·45 × 105
APOE ε4 1·18 (0·85 – 1·64) 0·10 1·25 (0·74 – 2·12) 0·15 1·01 (0·73– 1·39) 0·95 1·12 (0·90 – 1·38) 0·31
Deep ICH Mortality APOE ε2 0·68 (0·29 – 1·57) 0·36 1·11 (0·74 – 1·66) 0·78 0·90 (0·50 – 1·61) 0·72 0·98 (0·72 – 1·34) 0·90
APOE ε4 1·20 (0·52 – 2·78) 0·67 1·34 (0·83 – 2·18) 0·23 1·69 (0·52 – 5·48) 0·38 1·34 (0·91 – 1·99) 0·14
Lobar ICH Poor Outcome* APOE ε2 1·47 (1·10 – 2·0) 0·009 1·67 (1·15 – 2·43) 0·007 1·46 (1·02 – 2·65) 0·039 1·52 (1·25 – 1·85) 1·74 × 105
APOE ε4 1·24 (0·83 – 1·85) 0·08 1·21 (0·80 – 1·85) 0·13 1·00 (0·79 – 1·26) 0·99 1·08 (0·90 – 1·30) 0·39
Deep ICH Poor Outcome* APOE ε2 0·71 (0·41 – 1·25) 0·24 1·05 (0·68 – 1·63) 0·81 0·66 (0·26 – 1·67) 0·38 0·87 (0·63 – 1·20) 0·40
APOE ε4 1·24 (0·59 – 2·61) 0·57 1·14 (0·76 – 1·71) 0·52 1·15 (0·27 – 4·90) 0·85 1·61 (0·82 – 1·64) 0·40
*

Defined as modified Rankin Scale 3 – 6 at 90 days post-ICH

OR = Odds Ratio, ICH = Intracerebral Hemorrhage, 95% CI = 95% Confidence Interval